|
Market Closed -
Other stock markets
|
Pre-market 07:33:28 am | |||
| 1.22 USD | -8.96% |
|
1.27 | +4.10% |
| May. 07 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| May. 07 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
Nov 13 (Reuters) - Aclaris Therapeutics on Monday said it will stop development of its rheumatoid arthritis treatment after it failed in a mid-stage trial. (Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.19% | 86.94M | |
| +22.56% | 46.71B | |
| -1.51% | 41.52B | |
| +48.83% | 41.8B | |
| -3.42% | 29.55B | |
| +10.13% | 25.78B | |
| -20.44% | 19.26B | |
| +26.45% | 11.98B | |
| -0.14% | 12.14B | |
| -0.47% | 12.08B |
ACLARIS THERAPEUTICS, INC. 